RASSF2 methylation is a strong prognostic marker in younger age patients with Ewing sarcoma
暂无分享，去创建一个
R. Grimer | S. Avigad | E. Maher | F. Latif | S. Vaiyapuri | A. Dallol | E. Arrigoni | A. Brini | T. Kishida | S. Gharanei | T. Hiruma | A. Alholle | Abdullah Alholle